Previous Close | 15.68 |
Open | 15.96 |
Bid | 15.40 x 100 |
Ask | 15.50 x 100 |
Day's Range | 14.87 - 16.42 |
52 Week Range | 11.83 - 28.80 |
Volume | |
Avg. Volume | 668,548 |
Market Cap | 760.513M |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -5.87 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 39.25 |
Comprehensive Analysis of Financial Performance and Future Outlook
REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences:
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript May 8, 2024 REGENXBIO Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to REGENXBIO’s First Quarter 2024 Earnings Conference Call. At this […]